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Background: Major Depressive Disorder is one of the most challenging mental health problems of our time.
Although effective psychotherapeutic treatments are available, many patients fail to demonstrate clinically
significant improvements. Difficulties in emotion regulation have been identified as putative risk and maintaining
factors for Major Depressive Disorder. Systematically enhancing adaptive emotion regulation skills should thus help
reduce depressive symptom severity. However, at this point, no study has systematically evaluated effects of
increasing adaptive emotion regulation skills application on symptoms of Major Depressive Disorder. In the
intended study, we aim to evaluate stand-alone effects of a group-based training explicitly and exclusively targeting
general emotion regulation skills on depressive symptom severity and assess whether this training augments the
outcome of subsequent individual cognitive behavioral therapy for depression.
Methods/Design: In the evaluation of the Affect Regulation Training, we will conduct a prospective
randomized-controlled trial. Effects of the Affect Regulation Training on depressive symptom severity and
outcomes of subsequent individual therapy for depression will be compared with an active, common factor
based treatment and a waitlist control condition. The study sample will include 120 outpatients meeting criteria
for Major Depressive Disorder. Depressive symptom severity as assessed by the Hamilton Rating Scale will serve
as our primary study outcome. Secondary outcomes will include further indicators of mental health and changes
in adaptive emotion regulation skills application. All outcomes will be assessed at intake and at 10 points in time
over the course of the 15-month study period. Measures will include self-reports, observer ratings, momentary
ecological assessments, and will be complemented in subsamples by experimental investigations and the
analysis of hair steroids.
Discussion: If findings should support the hypothesis that enhancing regulation skills reduces symptom severity
in Major Depressive Disorder, systematic emotion regulation skills training can enhance the efficacy and
efficiency of current treatments for this severe and highly prevalent disorder.
Trial registration: This study is registered with ClinicalTrials.gov, number NCT01330485.
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Major Depressive Disorder (MDD) is currently one of the
most relevant mental health problems for individuals and
societies. With life-time prevalence rates greater than 15%
[1] and rates of chronicity around 20% [2], MDD ranks
fourth among all medical and psychiatric disorders when
considering disease burden, and worldwide it is the num-
ber one cause of disability [3]. Treatments for MDD have
been shown to be effective [2,4,5]. However, previous out-
come studies also indicate that many patients still suffer
from residual symptoms [6] and are likely to relapse
within two years after treatment [7]. These findings indi-
cate the need to enhance current psychotherapeutic treat-
ments for MDD.
In an attempt to improve upon existing treatments,
research has recently focused on deficits in emotion
regulation (ER) as risk factors for the development and
maintenance of MDD [8-10]. ER refers to implicit or ex-
plicit processes involved in attempts to change the qual-
ity, the intensity, or the duration of undesired affective
states in accordance with situational demands, bio-
logical needs, and individual goals [11-13]. Focusing on
aspects relevant to clinical utilization, Berking and col-
leagues [8,14-16] have conceptualized adaptive ER
as the situation-dependent interplay of the abilities to
(1) become aware of, (2) identify and label, (3) gain proper
understanding of, (4) adaptively modify or (5) accept and
tolerate affective reactions, (6) approach and confront sit-
uations likely to trigger negative affects when necessary to
attain personally relevant goals, and (7) provide compas-
sionate self-support in distressing situations. These abilities
have been proposed to help maintain a sense of control in
distressing situations and thus reduce the risk of depression
[4,14]. Adaptive ER skills are also believed to help prevent,
reduce or shorten the intensity or duration of dysphoric
states that have been found to reactivate depressive think-
ing patterns contributing to the (re-)occurrence of major
depressive episodes [17,18].
Consistent with these assumptions, deficits in ER have
been linked to depressive and other psychopathological
symptoms; successful application of adaptive ER skills was
positively related to indicators of mental health [19,20].
Longitudinal [21,22] and experimental [9,23,24] studies
support deficits in ER as important antecedents of MDD.
In treatment outcome studies, interventions that included
work on ER deficits were shown to be effective in treatment
for MDD, e.g., Dialectical Behavioral Therapy [25-27],
Emotion-Focused Therapy [28,29], and Affect Regulation
Training (ART) [8,14,15].
Among all treatments targeting ER, ART is likely the
only transdiagnostic program that explicitly and exclu-
sively aims to enhance general ER skills in at-risk and clin-
ical populations. Previous studies have shown preliminary
support for the efficacy of ART. In police officers, a groupthat had been shown to display significantly lower levels of
adaptive ER competencies than the normal population,
ART helped to enhance adaptive ER skills application [30].
In clinical settings, the ART program was evaluated in
samples of inpatients. A randomly selected subgroup of
patients meeting criteria for any mental disorder was of-
fered to replace part of their regular cognitive behavioral
therapy (CBT) with an abbreviated version of ART. Pa-
tients in the ART condition displayed significantly greater
increases in adaptive ER, greater decreases in MDD and
negative affect, and greater increases in positive affect than
patients receiving only conventional CBT [19]. In a pro-
spective randomized controlled trial on individuals meet-
ing criteria for MDD [8], patients allocated to a condition
in which some CBT sessions were replaced by a short ver-
sion of ART also showed greater gains in the acquisition
of health-relevant ER skills (modification, acceptance and
tolerance of undesired emotions as well as effective self-
support) and greater reductions of depressive symptoms
when compared to patients in the regular CBTcondition.
Despite these encouraging findings, existing research on
ART is limited by a number of factors. First, previous clin-
ical studies used a short version of ART. Second, ART has
not yet been compared with an untreated control condition
or with a condition that accounts for unspecific therapeutic
factors. Third, it has not yet been investigated whether
ART would augment the effects of other empirically-
evidenced treatments for MDD (possibly because enhanced
ER skills might allow patients to engage more intensely in
the therapeutic process, [31]). Finally, in previous study out-
comes the effectiveness of ART was exclusively assessed
through self-report measures and only at pre- and post-
treatment.
In an attempt to clarify whether experimentally enhan-
cing general ER skills reduces depressive symptom severity
and whether fostering adaptive ER skills enhances the out-
come of subsequent individual CBT for depression (iCBT-
D), we will evaluate the efficacy of ART in a prospective
randomized controlled trial. Stand-alone and augmenting
effects of ART will be compared with a waitlist control
condition and a condition controlling for active ingredi-
ents common to most empirically evidenced treatments.
Primary (depressive symptom severity) and secondary out-
comes will be assessed at intake and 10 points over the
course of the study. Measurements will include self-reports,
observer ratings, ecological momentary assessments (EMA)
[32] and will include experimental investigations and the
analysis of hair steroids in subsamples.
Methods/Design
The study is designed as a prospective randomized con-
trolled trial in an outpatient setting. Following three ses-
sions with their individual therapists, enrolled patients will
be assigned to the ART group, an active common factor-
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control group using a computerized randomization tool
(randomisation.net). Group therapies will be provided for
18 hours over the course of 8 weeks. Participants in the
waiting condition will be offered to participate in ART
after completion of the study. Following the group and a
4-week follow-up waiting phase, all participants will re-
ceive 16 hours of standardized and manualized iCBT for
depression. Individual treatment will be continued beyond
the study if necessary. An overview of the study design is
illustrated in Figure 1. The study has been approved by
the ethical committee of the German Psychological Soci-
ety and of the University of Marburg. It was registered
with ClinicalTrials.gov, number NCT01330485.
Inclusion and exclusion criteria
Inclusion criteria will include MDD as the primary diagno-
sis, age 18 or above, and sufficient German language skills.
Exclusion criteria will include high risk of suicide, indication
of substantial secondary gain (e.g., compensation issues),
additional psychotherapeutic treatments, comorbid psych-
otic, substance-related, bipolar disorders, organic brain or
other severe medical disorders, and severe cognitive impair-
ments. Other comorbid disorders, including personality dis-
orders, will be accepted to increase validity of the study.
Recruitment
Study participants will be recruited at outpatient treat-
ment centers in Marburg, Mainz, and Kassel. Potential
participants will be screened on eligibility and provided
with study information on the phone. Interested and po-
tentially eligible patients will receive additional written in-
formation on the study and be invited to a Structured
Clinical Interview for DSM-IV Axis I and II (SCID I, II) in
one of the study centers. Patients meeting inclusion cri-
teria and having provided informed consent will be in-
cluded in the study. Recruitment will be conducted
consecutively, that is, 10 to 15 individuals at a time will be




Figure 1 Overview of design and assessments. ART = Affect Regulation
C = Control Group. iCBT = individual Cognitive Behavioral Therapy.Interventions
Interventions will include ART and CFT-C as group in-
terventions and individual CBT for MDD.
Affect Regulation Training (ART)
ART was developed as an adjunctive or stand-alone trans-
diagnostic and group-based intervention, explicitly focusing
on an increase in adaptive ER in individuals who meet cri-
teria for mental disorders or are at-risk for developing men-
tal health problems. To foster effective ER, ART utilizes
elements from various psychotherapeutic approaches as
cognitive behavioral therapy [33], dialectical behavioral
therapy [27] emotion focused therapy [29], mindfulness-
based interventions [34], neuro-psychotherapeutic transla-
tional approaches [35], compassion-based therapy [36,37],
problem solving therapies [38], and strength-focused inter-
ventions [39,40]. At the beginning of the training, partici-
pants are provided with information on emotions including
biological and psychological origins, functions, risks, and
benefits of emotional reactions. Then seven “vicious cycles”
based on findings from the affective neurosciences and
deemed important in the long-term maintenance of nega-
tive affect, are presented. Individuals are taught skills to
break these cycles and enhance effective ER. These skills in-
clude muscle and breathing relaxation, nonjudgmental
emotional awareness, acceptance, and tolerance, compas-
sionate self-support, the identification of causes of emo-
tional reactions, and modification of affective states. In the
building of ER skills, special emphasis is placed on the im-
portance of regular training. Additional information on
ART is provided in the ART manual [14-16].
Common Factor Treatment-Control (CFT-C)
CFT-C was established as an active control group to ac-
count for unspecific change mechanisms of psychotherapy
(i.e., therapeutic alliance, resource activation, problem ac-
tivation, motivational clarification, and problem solving)
[35,39]. Following the identification of personally relevant
goals and associated motives, acceptance is targeted foron Follow-up iCBTCFT-C
ART
WL-C
T1 T2-4 T5 T6 T7-10
Training. CFT = Common Factor-based Treatment. WL =Wait-List.
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solving processes are initiated for achievable goals. Prob-
lem solving steps that are taught include the identification
and a detailed description of problems and relevant situ-
ational features, the definition of goals, the development,
evaluation, selection, and processing of solutions, and pro-
cesses of success monitoring and reinitiating the problem
solving or acceptance processes when necessary.
Individual Cognitive Behavioral Therapy for
Depression (iCBT-D)
Individual therapy will cover a 4-month period with 16
(weekly) 50-min sessions in total. Treatment will follow a
manualized protocol based on procedures developed by
Hautzinger [41], which includes psycho-education on
MDD, behavioral activation, cognitive restructuring, social
skills training, stress reduction, and relapse prevention.
Assessments
Participants will be assessed at intake and at 10 points
over the course of the study: before (T1), during (T2-4),
and after the group-based phase (T5), after the subsequent
4-week follow-up waiting phase before individual CBT
starts (T6), during (T7-9), and post the first four months
of individual CBT (T10). Measures will include self-report
questionnaires, interviews, observer-based ratings, EMA,
experimental investigations, and analyses of hair steroids.
Questionnaires will all be provided in paper pencil format
and in German language. Interviews will be conducted
face-to-face by intensively trained Master’s students
majoring in clinical psychology who will closely be super-
vised by psychotherapists and psychotherapists in training
for CBT, all of whom have Master’s degrees in clinical
psychology. Participants will be provided with iPhones for
the EMA. Over 7-day periods, time-contingent assess-
ments will be taken 3 times per day and one hour after
each of the three assessments. Participants will be given
the chance to supplement time-contingent assessments
with event-contingent assessments whenever they feel sig-
nificantly distressed. Enrolled patients will also be asked to
participate in an experimental investigation of ER skills
and to provide hair probes. Participants will be compen-
sated 50 Euros for the burden associated with study diag-
nostics, and an additional 20 Euros will be provided for
participating in the experiment or providing hair probes.
An overview of study variables, assessment points, and
instruments is provided in Table 1.
Primary outcome
The level of depressive symptom severity as assessed by
the Hamilton Rating Scale for Depression (HRSD) [42]
will serve as the primary study outcome. The HRSD is a
clinician-administered semi-structured interview that as-
sesses symptoms of MDD. Based on patients’ responses,clinicians rate the degree of 24 symptoms such as de-
pressed mood, feelings of guilt, sleeping disturbances, and
anxiety on 3-point or 5-point Likert scales. Higher sum
scores indicate greater symptom severity. The cut-off
points of 10, 19, 27, and 35 represent thresholds for mild,
moderate, severe, and very severe depression, respectively.
The HRSD is sensitive to change and corresponds well
with overall clinical ratings of severity [43,44].
Socio-demographic variables
The following socio-demographic data will be collected:
age, gender, marital status, partnership, children, current
living situation, educational level, occupation learned,
occupation held, and immigration.
Diagnostics
The Structured Clinical Interviews for DSM-IV Axis I and
II (SCID I, II) [45] will be used to assess MDD and comor-
bid disorders. The SCID is a structured interview that as-
sesses psychiatric diagnosis defined in the Diagnostic and
Statistical Manual of the American Psychiatric Associ-
ation, 4th edition (DSM-IV). The SCID II includes a
screening questionnaire to limit the number of questions
of the subsequent interview. DSM-5 diagnosis for MDD
will be added when possible.
Stressors
The List of Situational Stressors (LSS) will assess for po-
tential cues of negative emotional reactions to 11 daily
events. Individuals are asked to rate how often within the
last week they experienced stressors such as arguments
with a friend, romantic partner or family member (inter-
personal domain), high workload (work-related), financial
problems (financial domain), and trouble with means of
transport (everyday stressors). The scale has previously
been used in a study on affective reactivity as a predictor
of depressive symptoms [46].
Additional indicators of mental health
The Beck Depression Inventory II (BDI II) [47] will be in-
cluded in this study as a secondary measure of depressive
symptom severity. The BDI II is a widely used 21-item
self-report measure of somatic, behavioral, emotional, and
cognitive signs of depression. Good reliability and validity
have previously been demonstrated [48].
An unpublished German translation of the Scales of
Psychological Well-Being (SPWB) [49] will be used as
an indicator of psychological well-being. The SPWB in-
cludes scales for autonomy, environmental mastery,
personal growth, positive relations with others, purpose
in life, and self-acceptance. Given that psychometric
analyses of the SPWB have not always supported the
proposed six factor structure [50,51], we will use the
total score in this study. High internal consistency and
Table 1 Overview of study variables and instruments
Domain Instrument T0 T1 T2 T3 T4 T5 T6 T7 T8 T9 T10
Depressive symptom severity
(primary outcome)
Hamilton rating scale for depression ✕ ✕ ✕ ✕
Diagnostics Structured clinical interview for DSM-IV Axis I, II ✕ ✕ ✕
Stressors List of situational stressors ✕ ✕ ✕ ✕ ✕ ✕ ✕ ✕ ✕ ✕
Additional indicators of mental health Beck depression inventory II ✕ ✕ ✕ ✕ ✕ ✕ ✕ ✕ ✕ ✕
Scales of psychological well-being ✕ ✕ ✕ ✕ ✕ ✕ ✕ ✕ ✕ ✕
Pos. and neg. affect schedule ✕ ✕ ✕ ✕ ✕ ✕ ✕ ✕ ✕ ✕
Short scales of affective states relevant for psychotherapy ✕ ✕ ✕ ✕ ✕ ✕ ✕ ✕ ✕ ✕
SHARP/others ✕ ✕ ✕ ✕
Brief symptom inventory ✕ ✕ ✕ ✕
Depression anxiety and stress scale ✕ ✕ ✕ ✕ ✕ ✕ ✕ ✕ ✕ ✕
Emotion regulation Emotion reg. skills questionnaire ✕ ✕ ✕ ✕ ✕ ✕ ✕ ✕ ✕ ✕
ERSQ- others ✕ ✕ ✕ ✕
Emotion reg. skills questionnaire- emotion specific ✕ ✕ ✕ ✕ ✕ ✕ ✕ ✕ ✕ ✕
ERSQ-ES- others ✕ ✕ ✕ ✕
Difficulties in emotion reg. scale ✕ ✕ ✕ ✕
Negative mood regulation scale ✕
Trait meta-mood scale ✕
Confounding variables Self-efficacy scale ✕ ✕ ✕ ✕
Multidim. perfectionism scale ✕ ✕ ✕ ✕
Rosenberg self-esteem scale ✕ ✕ ✕ ✕
Additional assessments Ecological momentary assessment ✕ ✕
Laboratory experiment ✕ ✕
Hair steroids ✕ ✕ ✕
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original validation study [49].
Positive and negative affective states will be assessed
using the Positive and Negative Affect Schedule (PANAS)
[52]. On 5-point Likert scales (0 = not at all to 4 = almost
always), participants are asked to rate the frequency of 20
affective states. Within a previous validation study [52],
good internal consistency was revealed, and associations
with related constructs such as anxiety, depression, and
neuroticism were significant and in the expected direc-
tions. To assess more specific emotional reactions, Berking
developed the Short Scales for the Assessment of Affective
States Relevant in Psychotherapeutic Treatments- Self/
Other (SHARP). On 4-point Likert scales, participants rate
how often they experienced 50 different emotions in the
past week.
To obtain continuous information on comorbid
symptom severity, a global severity index will be com-
puted on all but the depression scales of the Brief
Symptom Inventory (BSI) [53]. The BSI is a screening
tool for psychological disturbance including depression,
somatization, obsessive-compulsive symptoms, inter-
personal sensitivity, anxiety, hostility, phobic anxiety,paranoid ideation, and psychoticism. Adequate psychomet-
ric properties with very high internal consistency for the
total score have previously been reported for the German
scale [54]. Accounting for high comorbidity between MDD
and anxiety disorders [55], the Depression Anxiety and
Stress Scale (DASS-21) [56] will also be administered. The
DASS is a 42-item self-report instrument designed to meas-
ure the three related negative emotional states of depres-
sion, anxiety and stress. To our knowledge, no validation
study of the German DASS has been published to date. For
the English scale, good to excellent internal consistency
scores were reported, and associations with other measures
of depression, anxiety, and stress were within the high
range [57].
Emotion regulation
Successful application of adaptive ER skills will be
assessed through self-reports and observer-based rat-
ings using the Emotion Regulation Skills Questionnaire-
Self/Other (ERSQ) [20]. The ERSQ is a 27-item measure
addressing the application of nine competencies included
in the ART model of effective ER (i.e., Awareness, Modifi-
cation, Acceptance, Understanding, Sensations, Clarity,
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sults from validation studies [20] indicate that both the
total score and the subscales of the ERSQ have good in-
ternal consistencies and adequate retest-reliability. Associ-
ations with other scales supported the scale’s convergent
and discriminant validity [20]. To assess ER with regard to
specific affective states, the Emotion Regulation Skills
Questionnaire- Emotion Specific-Self/Other (ERSQ-ES)
[58] will be used. Sound psychometric properties have pre-
viously been reported for this scale. The observer-based
versions of the ERSQ and ERSQ-ES were developed for
the purpose of this study and will be evaluated on the
basis of study data.
Further applied ER scales with established psychomet-
ric properties include a German translation of the Diffi-
culties in Emotion Regulation Scale (DERS) [59], the
Negative Mood Regulation Scale (NMR) [60], and the
Trait Meta-Mood Scale (TMMS) [61]. The DERS as-
sesses difficulties in emotional awareness, emotional ac-
ceptance, goal-directed behaviors and the application of
effective ER strategies. The NMR was designed as a
measure of individuals’ general expectancies that emo-
tional states can effectively be changed through ways of
behaving or thinking. The TMMS is a measure of emo-
tional intelligence including the components of emo-
tional attention, clarity, and mood repair.
Confounding variables
To control for potential confounds, we will assess general
self-efficacy with a 10-item, validated German scale (Skala
zur Allgemeinen Selbstwirksamkeitserwartung, ASE) [62].
Perfectionism will be assessed by the Multidimensional
Perfectionism Scale (MPS) [63], including 35 items on
concerns about mistakes, personal standards, parental ex-
pectations, parental criticism, doubts about actions, and
organization. The Rosenberg Self-Esteem scale (RSE) [64]
will be used as a measure of self-esteem. Adequate psy-
chometric properties of these scales have been reported in
the cited studies.
Other outcome measures
Targeting the issue of cognitive distortion and to in-
crease ecological validity, EMA will be implemented as a
real-time assessment of ER, affective states, and affective
changes. Within EMA, affective states and ER will be
assessed by short scales of the SHARP and ERSQ-ES.
Additional questions will address location, activity, and
interaction partners. To reduce self-report biases and to
yield further information on causality, the effects of
adaptive ER on positive and negative affect will be tested
experimentally. In laboratory settings, negative and posi-
tive affective states will be induced by music and self-
related statements using the Velten [65] method. Partici-
pants will be provided with oral instructions of adaptiveER strategies (i.e., acceptance, positive reappraisal, com-
passionate self-support, positive appreciation). Hair probes
will be taken to gather data for biological features of
MDD. Elevated levels of hair steroids (i.e., cortisol and
cortisone) have frequently been linked to MDD [66]. In
the analyses of hair steroids, we will use liquid chromatog-
raphy with linked tandem mass spectrometry.
Participants
Sample size for the group phase was set to N = 120 (n = 40
per condition). A minimum of n = 90 individuals (n = 30
per condition) is expected to complete individual CBT.
Targeted sample sizes are based on power calculations.
The intended sample of 120 individuals can be expected
to provide sufficient power to detect small effects [67].Statistical analyses
Data will be analyzed according to intent to treat and
treatment completers principles. The intent to treatment
analyses will be the primary level of analyses. Mixed effect
modeling will serve as the main approach in the analyses
of study data and in the treatment of missing values.
Growth curves of ER and depressive symptom severity
will be computed per group on the basis of assessments
before (T1-T5) and during individual CBT (T6-T10) to
test for stand-alone and augmentation effects of ART.
Slopes for the ART condition are hypothesized to be lar-
ger than those for the active or waitlist control groups,
indicating the effectiveness of adaptive ER skills applica-
tion enhancement and a decrease in depressive symptom
severity by the ART program. In the secondary analyses,
we will test for ART effects on well-being, positive, and
negative affect. Bootstrapping enhanced, multilevel me-
diation analyses [68] will be conducted to test ER as a
mediator of health improvements in the ART condition.
Analyses will be conducted computing a total score of
adaptive ER and separately for the different ART skills to
understand the importance of specific ER skills. Moder-
ated mediation analyses [69] will be used to examine the
importance of specific ER skills in the mediation of posi-
tive health outcomes. Latent growth curve and latent
change score modeling [70] will further be used in the in-
vestigation of reciprocal associations between levels and
changes of ER and health outcomes. Comorbid symptom
severity and potential confounding variables (i.e., general
self-efficacy, perfectionism, and self-esteem) will be in-
cluded in the analyses as moderating variables. The ana-
lyses of EMA and the experimental and biological data
will serve to increase the validity of the ART evaluation.
SEM-based Multi-Trait, Multi-Method approaches will be
applied in the investigation of psychometric properties
and in the comparison of outcomes by different assess-
ment methods.
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We should find support for our hypothesis that systemat-
ically enhancing general ER skills helps reduce depressive
symptoms in individuals meeting criteria for MDD, given
that deficits in ER are commonly considered a relevant
risk and maintaining factor for this disorder. Former stud-
ies on ART, a program explicitly and exclusively focusing
on an increase in adaptive ER skills application, have pro-
vided preliminary support for this assumption [8,19].
However, the validity of these studies has been compro-
mised through a number of limitations such as the lack of
an untreated control condition or a condition that con-
trols for unspecific therapeutic factors, the lack of testing
for augmentation effects of the ART on other treatments
such as individual CBT for depression, and the exclusive
use of self-reports at pre- and post-treatment. To improve
on these limitations of previous studies and to advance the
literature on associations between ER and MDD, we will
systematically evaluate ART in a prospective randomized
controlled trial.
This study will provide significant contributions to
the literature. First, by controlling for time and unspe-
cific treatment effects, the results will provide insight
into the effects of enhancing the application of adap-
tive ER skills on symptoms of MDD. Second, from the
two-phase design of this study that includes a period of
individual CBT following the group phase, the stand-
alone effects of ART on ER and depressive symptom
severity can be tested, as well as the augmentation ef-
fects of ART on CBT outcomes. Third, the application
of various measures, including self-reports, observer-
based ratings, momentary assessments, experimental
investigations, and the analysis of hair probes, will aug-
ment the reliability of findings and help to overcome
methodological restrictions such as cognitive distor-
tion and social desirability in retrospective testing and
self-reports. The implementation of various assess-
ment points over the course of the study will allow for
detailed analyses of changes in and associations be-
tween ER and depressive symptom severity.
In light of the methodological strengths, the present
study has the potential to substantially increase know-
ledge on ER processes that underlie and maintain MDD.
Given the likely importance of deficits in ER across dis-
orders, this study might also yield a better understanding
of comorbidity in MDD, which currently is one of the
major challenges in the treatment of depressive disor-
ders. Therapeutically, fostering adaptive ER skills appli-
cation by ART might substantially improve treatment
outcomes for individuals with depressive and possibly
also comorbid disorders.Competing interests
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